WuXi Biologics (Cayman) Inc. (WXXWY)
OTCMKTS · Delayed Price · Currency is USD
6.68
-0.17 (-2.48%)
Apr 2, 2025, 3:59 PM EST

WuXi Biologics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
13,8219,28116,00032,43250,13554,159
Upgrade
Market Cap Growth
-41.99%-41.99%-50.67%-35.31%-7.43%230.33%
Upgrade
Enterprise Value
13,5329,14615,71731,76448,75153,941
Upgrade
Last Close Price
6.764.437.4515.0723.4426.31
Upgrade
PE Ratio
30.0620.1933.3750.6193.99209.36
Upgrade
PS Ratio
3.633.636.6614.6530.9563.00
Upgrade
PB Ratio
1.491.492.586.189.7416.92
Upgrade
P/TBV Ratio
1.701.702.966.7910.5617.69
Upgrade
P/FCF Ratio
-182.37---
Upgrade
P/OCF Ratio
-24.3140.3792.82187.95
Upgrade
EV/Sales Ratio
5.303.586.5414.3530.1062.75
Upgrade
EV/EBITDA Ratio
17.7311.9622.6143.2285.50198.82
Upgrade
EV/EBIT Ratio
21.5814.5628.3450.3697.69234.41
Upgrade
EV/FCF Ratio
-179.13---
Upgrade
Debt / Equity Ratio
0.110.110.100.120.130.16
Upgrade
Debt / EBITDA Ratio
0.890.890.890.861.181.85
Upgrade
Debt / FCF Ratio
--7.33---
Upgrade
Asset Turnover
0.330.330.320.330.280.24
Upgrade
Inventory Turnover
6.716.715.044.313.944.15
Upgrade
Quick Ratio
1.981.982.351.561.852.49
Upgrade
Current Ratio
2.732.732.781.982.373.16
Upgrade
Return on Equity (ROE)
8.82%8.82%8.90%13.20%13.09%10.02%
Upgrade
Return on Assets (ROA)
5.05%5.05%4.63%5.81%5.43%4.03%
Upgrade
Return on Capital (ROIC)
5.79%5.79%5.51%7.00%6.47%4.78%
Upgrade
Return on Capital Employed (ROCE)
9.50%9.50%8.00%10.80%8.90%6.10%
Upgrade
Earnings Yield
3.33%4.95%3.00%1.98%1.06%0.48%
Upgrade
FCF Yield
-0.55%-0.15%-0.97%-1.17%
Upgrade
Buyback Yield / Dilution
2.80%2.80%0.62%1.04%-5.05%-5.30%
Upgrade
Updated Sep 20, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.